The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 02, 2026
Snapshot (as of Sep 02, 2026): Pfizer Inc. (PFE) pays a $1.72 annual dividend ($0.43 quarterly), yielding 6.02% at $28.55/share. Next ex-dividend date 2026-07-24. 15 consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 6.02%
Annual Dividend: $1.72 per share
Payout Ratio: 225.7% (based on depressed trailing earnings — see safety analysis below)
Ex-Dividend Date: 2026-07-24
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 55
Pfizer Inc. dividend income comes from one of the world's largest biopharmaceutical companies, with a portfolio spanning vaccines like Comirnaty and Prevnar, cardiovascular drugs like Eliquis, and oncology treatments like Ibrance. PFE currently pays a 6.15% dividend yield, placing it firmly in high-yield territory. The trailing annual dividend rate is $1.72 per share, paid quarterly, with the next ex-dividend date on July 24, 2026. With a beta of just 0.28, PFE stock moves far less than the broader market, a characteristic that tends to appeal to income-focused investors who prioritize low volatility.
Pfizer Inc. pays out 225.7% of earnings as dividends, a payout ratio classified as high (above 75%) — in fact, it far exceeds that threshold. The company's broad product base, including recurring demand for vaccines, oncology drugs, and treatments for chronic conditions, provides revenue across multiple therapeutic areas, though Pfizer Inc. dividend safety is directly challenged by a payout ratio that exceeds earnings entirely. The most significant pressure point is that the current dividend is not covered by reported earnings, meaning PFE depends on cash generation beyond net income to sustain the $1.72 annual payment.
Pfizer Inc. dividend history shows a CAGR of 5.6% per year from 2011 to 2025. Per-share payments grew from $0.80 to $1.72 over that period (2026 data is partial and excluded from this calculation, per Pfizer Inc. dividend 2026 reporting). The smallest annual increase in the window was 2.4% in 2024, signaling that recent growth has slowed considerably from the 10.0% peak increase recorded in 2012.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +2.4% | $1.60 (2022) | $1.72 (2025) |
| 5-Year | +2.5% | $1.52 (2020) | $1.72 (2025) |
| 10-Year | +4.4% | $1.12 (2015) | $1.72 (2025) |
PFE stock fits income-focused investors who want a high headline yield from a large, diversified biopharmaceutical business. The 6.15% yield is classified as high (above 4%) and sits above the 5-year average yield of 5.87%, which means the current yield is elevated relative to its own recent history. Growth has been present but slow, with the 5.6% CAGR moderating to just 2.4% in the most recent full year. The defining trade-off is straightforward: Pfizer Inc. offers a high current income stream, but the 225.7% payout ratio means that income rests on cash flow rather than earnings coverage, which introduces a layer of risk that income investors should weigh against the yield.
| Payment Date | Amount per Share |
|---|---|
| 2026-07-24 | $0.4300 |
| 2026-05-08 | $0.4300 |
| 2026-01-23 | $0.4300 |
| 2025-11-07 | $0.4300 |
| 2025-07-25 | $0.4300 |
| 2025-05-09 | $0.4300 |
| 2025-01-24 | $0.4300 |
| 2024-11-08 | $0.4200 |
| 2024-07-26 | $0.4200 |
| 2024-05-09 | $0.4200 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.2900 |
| 2025 | $1.7200 |
| 2024 | $1.6800 |
| 2023 | $1.6400 |
| 2022 | $1.6000 |
Project income from PFE with the PFE dividend calculator or track your full portfolio with the dividend tracker.